meglumine has been researched along with Bone Diseases in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
De Deene, Y; Dierick, A; Kunnen, M; Roels, H; Uyttendaele, D; Verstraete, KL | 1 |
Labaisse, MA; Maldague, BE; Malghem, JJ; Noel, HM; Vande Berg, BE | 1 |
Beltran, J; Chandnani, V; Kursunoglu-Brahme, S; McGhee, RA | 1 |
1 review(s) available for meglumine and Bone Diseases
Article | Year |
---|---|
Gadopentetate dimeglumine-enhanced MR imaging of the musculoskeletal system.
Topics: Bone Diseases; Contrast Media; Drug Combinations; Gadolinium; Gadolinium DTPA; Humans; Joint Diseases; Magnetic Resonance Imaging; Meglumine; Muscular Diseases; Organometallic Compounds; Pentetic Acid; Soft Tissue Neoplasms; Spinal Diseases | 1991 |
2 other study(ies) available for meglumine and Bone Diseases
Article | Year |
---|---|
Benign and malignant musculoskeletal lesions: dynamic contrast-enhanced MR imaging--parametric "first-pass" images depict tissue vascularization and perfusion.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Bone and Bones; Bone Diseases; Bone Neoplasms; Child; Contrast Media; Drug Combinations; Female; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Muscles; Muscular Diseases; Organometallic Compounds; Pentetic Acid; Sensitivity and Specificity; Soft Tissue Neoplasms | 1994 |
MR imaging of avascular necrosis and transient marrow edema of the femoral head.
Topics: Adult; Bone Diseases; Bone Marrow; Bone Marrow Diseases; Contrast Media; Edema; Epiphyses; Female; Femur Head; Femur Head Necrosis; Gadolinium; Hip Fractures; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Meglumine; Middle Aged; Organometallic Compounds | 1993 |